Developmental strategies for evasion of Arf tumor suppression

Cell Cycle

Volumn 9, Issue 1, 2010, Pages 14-15

  Volanakis, Emmanuel J ^a   Sherr, Charles J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Epigenetic silencing; Oncogenes; Stem cells; T cell ALL; Tumor initiation; Tumor progression

Indexed keywords

ARF PROTEIN; BMI1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; NOTCH RECEPTOR; RETINOBLASTOMA PROTEIN;

ACUTE LEUKEMIA; APOPTOSIS; CANCER INHIBITION; CARCINOGENESIS; EDITORIAL; ENZYME INHIBITION; GENE DELETION; GENE MUTATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 74549173736     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.1.10390     Document Type: Editorial

References (10)

1. Sherr CJ, et al. Cancer Cell 2002; 2:103-12.
2. Kamijo T, et al. Cell 1997; 91:649-59.
3. Volanakis EJ, et al. Blood 2009; EPub ahead of print.
4. Weng AP, et al. Science 2004; 306:269-71.
5. Aster JC, et al. Annu Rev Pathol 2008; 3:587-613.
6. Ferrando AA, et al. Cancer Cell 2002; 1:75-87.
7. Miyazaki M, et al. Immunity 2008; 28:231-45.
8. Mullighan CG, et al. Genes Dev 2008; 22:1411-5.
9. Dovey JS, et al. Proc Natl Acad Sci USA 2008; 105:11857-62.
10. Kim CF, et al. Cell 2005; 121:823-35.